Fariss MW - Search Results

1

Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects.

Neuzil J, Tomasetti M, Mellick AS, Alleva R, Salvatore BA, Birringer M, Fariss MW. Neuzil J, et al. Among authors: fariss mw. Curr Cancer Drug Targets. 2004 Jun;4(4):355-72. doi: 10.2174/1568009043332943. Curr Cancer Drug Targets. 2004. PMID: 15180501 Review.

2

Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.

Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schröder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J. Weber T, et al. Among authors: fariss mw. Clin Cancer Res. 2002 Mar;8(3):863-9. Clin Cancer Res. 2002. PMID: 11895920

3

Chemopreventive effect of dietary d-alpha-tocopheryl succinate supplementation on precancer colon aberrant crypt formation and vitamin E analogue levels in young and old rats.

Exon JH, South EH, Taruscio TG, Clifton GD, Fariss MW. Exon JH, et al. Among authors: fariss mw. Nutr Cancer. 2004;49(1):72-80. doi: 10.1207/s15327914nc4901_10. Nutr Cancer. 2004. PMID: 15456638

4

The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.

Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z. Fariss MW, et al. Cancer Res. 1994 Jul 1;54(13):3346-51. Cancer Res. 1994. PMID: 8012947

5

Vitamin E therapy in Parkinson's disease.

Fariss MW, Zhang JG. Fariss MW, et al. Toxicology. 2003 Jul 15;189(1-2):129-46. doi: 10.1016/s0300-483x(03)00158-6. Toxicology. 2003. PMID: 12821288 Review.

6

Growth inhibition of MCF-7 and MCF-10A human breast cells by alpha-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs.

Djuric Z, Heilbrun LK, Lababidi S, Everett-Bauer CK, Fariss MW. Djuric Z, et al. Among authors: fariss mw. Cancer Lett. 1997 Jan 1;111(1-2):133-9. doi: 10.1016/s0304-3835(96)04522-3. Cancer Lett. 1997. PMID: 9022138

7

Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria.

Fariss MW, Nicholls-Grzemski FA, Tirmenstein MA, Zhang JG. Fariss MW, et al. Free Radic Biol Med. 2001 Aug 15;31(4):530-41. doi: 10.1016/s0891-5849(01)00615-3. Free Radic Biol Med. 2001. PMID: 11498286

8

Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat.

Teng XW, Davies NM, Fukuda C, Good RL, Fariss MW. Teng XW, et al. Among authors: fariss mw. Biopharm Drug Dispos. 2005 Jul;26(5):195-203. doi: 10.1002/bdd.451. Biopharm Drug Dispos. 2005. PMID: 15900617

9

Direct high-performance liquid chromatographic analysis of D-tocopheryl acid succinate and derivatives.

Good RL, Roupe KA, Fukuda C, Clifton GD, Fariss MW, Davies NM. Good RL, et al. Among authors: fariss mw. J Pharm Biomed Anal. 2005 Sep 1;39(1-2):33-8. doi: 10.1016/j.jpba.2005.02.029. Epub 2005 Apr 13. J Pharm Biomed Anal. 2005. PMID: 16085132

10

alpha-Tocopheryl hemisuccinate administration increases rat liver subcellular alpha-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity.

Tirmenstein MA, Leraas TL, Fariss MW. Tirmenstein MA, et al. Among authors: fariss mw. Toxicol Lett. 1997 Jun 16;92(1):67-77. doi: 10.1016/s0378-4274(97)00036-2. Toxicol Lett. 1997. PMID: 9242359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page